Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2007 1
2009 3
2010 3
2012 4
2013 2
2014 3
2015 3
2016 2
2017 3
2018 1
2019 1
2020 1
2021 1
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.
Fisher MJ, Shih CS, Rhodes SD, Armstrong AE, Wolters PL, Dombi E, Zhang C, Angus SP, Johnson GL, Packer RJ, Allen JC, Ullrich NJ, Goldman S, Gutmann DH, Plotkin SR, Rosser T, Robertson KA, Widemann BC, Smith AE, Bessler WK, He Y, Park SJ, Mund JA, Jiang L, Bijangi-Vishehsaraei K, Robinson CT, Cutter GR, Korf BR; Neurofibromatosis Clinical Trials Consortium; Blakeley JO, Clapp DW. Fisher MJ, et al. Among authors: bijangi vishehsaraei k. Nat Med. 2021 Jan;27(1):165-173. doi: 10.1038/s41591-020-01193-6. Epub 2021 Jan 13. Nat Med. 2021. PMID: 33442015 Free PMC article. Clinical Trial.
Prospective assessment of risk biomarkers of sinusoidal obstruction syndrome after hematopoietic cell transplantation.
Han Y, Bidgoli A, DePriest BP, Méndez A, Bijangi-Vishehsaraei K, Perez-Albuerne ED, Krance RA, Renbarger J, Skiles JL, Choi SW, Liu H, Paczesny S. Han Y, et al. Among authors: bijangi vishehsaraei k. JCI Insight. 2023 May 22;8(10):e168221. doi: 10.1172/jci.insight.168221. JCI Insight. 2023. PMID: 37071469 Free PMC article. Clinical Trial.
The Role of MDM2 in Promoting Genome Stability versus Instability.
Saadatzadeh MR, Elmi AN, Pandya PH, Bijangi-Vishehsaraei K, Ding J, Stamatkin CW, Cohen-Gadol AA, Pollok KE. Saadatzadeh MR, et al. Among authors: bijangi vishehsaraei k. Int J Mol Sci. 2017 Oct 23;18(10):2216. doi: 10.3390/ijms18102216. Int J Mol Sci. 2017. PMID: 29065514 Free PMC article. Review.
Establishment and characterization of patient-derived xenograft of a rare pediatric anaplastic pleomorphic xanthoastrocytoma (PXA) bearing a CDC42SE2-BRAF fusion.
Damayanti NP, Saadatzadeh MR, Dobrota E, Ordaz JD, Bailey BJ, Pandya PH, Bijangi-Vishehsaraei K, Shannon HE, Alfonso A, Coy K, Trowbridge M, Sinn AL, Zhang ZY, Gallagher RI, Wulfkuhle J, Petricoin E, Richardson AM, Marshall MS, Lion A, Ferguson MJ, Balsara KE, Pollok KE. Damayanti NP, et al. Among authors: bijangi vishehsaraei k. Sci Rep. 2023 Jun 6;13(1):9163. doi: 10.1038/s41598-023-36107-2. Sci Rep. 2023. PMID: 37280243 Free PMC article.
Precision Medicine Highlights Dysregulation of the CDK4/6 Cell Cycle Regulatory Pathway in Pediatric, Adolescents and Young Adult Sarcomas.
Barghi F, Shannon HE, Saadatzadeh MR, Bailey BJ, Riyahi N, Bijangi-Vishehsaraei K, Just M, Ferguson MJ, Pandya PH, Pollok KE. Barghi F, et al. Among authors: bijangi vishehsaraei k. Cancers (Basel). 2022 Jul 25;14(15):3611. doi: 10.3390/cancers14153611. Cancers (Basel). 2022. PMID: 35892870 Free PMC article. Review.
Emerging targets for glioblastoma stem cell therapy.
Safa AR, Saadatzadeh MR, Cohen-Gadol AA, Pollok KE, Bijangi-Vishehsaraei K. Safa AR, et al. Among authors: bijangi vishehsaraei k. J Biomed Res. 2016 Jan;30(1):19-31. doi: 10.7555/JBR.30.20150100. Epub 2015 Sep 20. J Biomed Res. 2016. PMID: 26616589 Free PMC article.
Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors.
Pandya PH, Jannu AJ, Bijangi-Vishehsaraei K, Dobrota E, Bailey BJ, Barghi F, Shannon HE, Riyahi N, Damayanti NP, Young C, Malko R, Justice R, Albright E, Sandusky GE, Wurtz LD, Collier CD, Marshall MS, Gallagher RI, Wulfkuhle JD, Petricoin EF, Coy K, Trowbridge M, Sinn AL, Renbarger JL, Ferguson MJ, Huang K, Zhang J, Saadatzadeh MR, Pollok KE. Pandya PH, et al. Among authors: bijangi vishehsaraei k. Cancers (Basel). 2022 Dec 30;15(1):259. doi: 10.3390/cancers15010259. Cancers (Basel). 2022. PMID: 36612255 Free PMC article.
Enhancing anti-tumor potential: low-intensity vibration suppresses osteosarcoma progression and augments MSCs' tumor-suppressive abilities.
Xiong X, Huo Q, Li K, Cui C, Chang C, Park C, Ku B, Hong CS, Lim H, Pandya PH, Saadatzadeh MR, Bijangi-Vishehsaraei K, Lin CC, Kacena MA, Pollok KE, Chen A, Liu J, Thompson WR, Li XL, Li BY, Yokota H. Xiong X, et al. Among authors: bijangi vishehsaraei k. Theranostics. 2024 Jan 27;14(4):1430-1449. doi: 10.7150/thno.90945. eCollection 2024. Theranostics. 2024. PMID: 38389836 Free PMC article.
31 results